Drug Trial Radar · NCT05202262
A 24-Week Efficacy and Safety Study to Assess Budesonide and Formoterol Fumarate Metered Dose Inhaler in Adult and Adolescent Participants With Inadequately Controlled Asthma (VATHOS)
Last checked: Nov 19, 2026Latest source record: Jan 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
645
Actual
Start
Jan 12, 2022
Primary completion
Feb 26, 2025
Study completion Feb 26, 2025
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Jan 21, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a 24 week study to evaluate the efficacy and safety of budesonide and formoterol fumarate metered dose inhaler in adults and adolescents with inadequately controlled asthma.
Conditions
- Asthma
Interventions
BFF MDI 320/9.6 μgDrug
Budesonide/ Formoterol Fumarate (BFF) metered-dose inhaler (MDI), 320/9.6 μg
BFF MDI 160/9.6 μgDrug
Budesonide/ Formoterol Fumarate (BFF) metered-dose inhaler (MDI), 160/9.6 μg
BD MDI 320 μgDrug
Budesonide MDI (BD MDI), 320 μg
Open-label Symbicort TBH 320/9 μgDrug
Open-label Symbicort Turbuhaler 320/9 μg
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Forced Expiratory Volume in 1 Second (FEV1) Area Under the Curve 0 to 3 Hours (AUC0-3) at Week 24Time frame: At Week 24
Locations
142 sites in 7 countries. Site status is shown where the registry gives one.
Research Site
Chandler, Arizona
Research Site
Tucson, Arizona
Research Site
Bakersfield, California
Research Site
Fresno, California
Research Site
Huntington Beach, California
Research Site
La Palma, California
Research Site
Lincoln, California
Research Site
Los Angeles, California
Research Site
Los Angeles, California
Research Site
Los Angeles, California
Research Site
Newport Beach, California
Research Site
Northridge, California
Research Site
Sacramento, California
Research Site
San Diego, California
Research Site
San Diego, California
Research Site
San Jose, California
Research Site
Denver, Colorado
Research Site
Wheat Ridge, Colorado
Research Site
Cutler Bay, Florida
Research Site
DeLand, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Tampa, Florida
Research Site
Atlanta, Georgia
Research Site
Peoria, Illinois
Research Site
Lexington, Kentucky
Research Site
White Marsh, Maryland
Research Site
North Dartmouth, Massachusetts
Research Site
Farmington Hills, Michigan
Research Site
Columbia, Missouri
Research Site
Saint Charles, Missouri
Research Site
St Louis, Missouri
Research Site
Kalispell, Montana
Research Site
Missoula, Montana
Research Site
Bellevue, Nebraska
Research Site
Omaha, Nebraska
Research Site
Henderson, Nevada
Research Site
North Las Vegas, Nevada
Showing 40 of 142 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.